Table 1 Patient demographics and characteristics
Variable | All Patients N = 83 (%) | TAVR N = 56 (67%) | SAVR N = 27 (32%) | P- Value | |
|---|---|---|---|---|---|
Age, mean (SD) | 73.4 (10.7) | 77.29 (8.69) | 65.41 (10.05) | < 0.001 | |
Gender, n (%) | 0.79 | ||||
Male | 60 (72.3%) | 41 (73.2%) | 19 (70.4%) | ||
Female | 23 (27.7%) | 15 (26.8%) | 8 (29.6%) | ||
Race**, n (%) | 0.99 | ||||
White | 79 (96.3%) | 53 (96.4%) | 26 (96.3%) | ||
Black | 3 (3.7%) | 2 (3.6%) | 1 (3.7%) | ||
Weight, mean (SD) | 84.06 (23.4) | 81.53 (22.56) | 89.29 (24.7) | 0.16 | |
BMI, mean (SD) | 28.3 (7.1) | 27.35 (6.84) | 30.19 (7.52) | 0.09 | |
Medical History, n (%) | |||||
Smoking | 17 (20.5%) | 10 (18%) | 7 (25.9%) | 0.00 | |
PVD | 25 (30.1%) | 21 (37.5%) | 4 (14.8%) | 0.04 | |
MI | 24 (28.9%) | 21 (37.5%) | 3 (11.1%) | 0.21 | |
HTN | 65 (78.3%) | 43 (76.8%) | 22 (81.5%) | 0.63 | |
DM | 43 (51.8%) | 27 (48.2%) | 16 (59.3%) | 0.59 | |
Atrial fibrillation/flutter | 25 (30.1%) | 18 (32.1%) | 7 (25.9%) | 0.57 | |
Paroxysmal | 13 (15.7%) | 7 (29.2%) | 6 (22.2%) | ||
Persistent | 8 (9.6%) | 7 (29.2%) | 1 (3.7%) | ||
Not listed | 4 (4.8%) | 4 (16.7%) | 0 (0%) | ||
NYHA HF Class, n(%) | 79 | 55 | 24 | 0.35 | |
I | 2 (2.4%) | 1 (1.8%) | 1 (3.7%) | 0.55 | |
II | 7 (8.4%) | 3 (5.4%) | 4 (14.8%) | 0.11 | |
III | 35 (42.2%) | 23 (41.1%) | 12 (44.4%) | 0.51 | |
IV | 35 (42.2%) | 28 (50.0%) | 7 (25.9%) | 0.08 | |
Procedure History, n(%) | |||||
Percutaneous Coronary Intervention | 27 (32.5%) | 25 (44.6%) | 2 (7.4%) | 0.001 | |
CABG | 21 (25.3%) | 19 (33.9%) | 2 (7.4%) | 0.009 | |
PPM | 7 (8.4%) | 7 (12.5%) | 0 (0%) | 0.056 | |
ICD | 17 (20.5%) | 15 (26.8%) | 2 (7.4%) | 0.048 | |
Aortic valve Procedure | 16 (19.3%) | 13 (23.2%) | 3 (11.1%) | 0.195 | |
Aortic valve replacement | 3 (3.6%) | 3 (5.4%) | 0 (0%) | 0.390 | |
Aortic valve balloon angioplasty | 13 (15.7%) | 10 (17.9%) | 3 (11.1%) | 0.390 | |
Non-Aortic valve procedure | 3 (3.6%) | 2 (3.6%) | 1 (3.7%) | 0.976 | |